| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| systematic review | Q1504425 |
| review article | Q7318358 |
| P2093 | author name string | Junjiang Fu | |
| Xianqin Zhang | |||
| Saber Imani | |||
| Shangyi Fu | |||
| Hossein Hosseinifard | |||
| P2860 | cites work | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 |
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 | ||
| Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer | Q39217102 | ||
| Circulating miR-34a levels are reduced in colorectal cancer | Q39610241 | ||
| Breast cancer statistics, 2015: Convergence of incidence rates between black and white women | Q40379855 | ||
| The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells | Q40514866 | ||
| Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression. | Q50924410 | ||
| Serum tissue polypeptide-specific antigen is an independent predictor in breast cancer. | Q51191519 | ||
| Diagnostic efficacy of CA 15-3 and CEA in the early detection of metastatic breast cancer-A retrospective analysis of kinetics on 743 breast cancer patients. | Q52864562 | ||
| Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. | Q53259995 | ||
| Is detection of endocrine cells in breast adenocarcinoma of diagnostic and clinical significance? | Q60286277 | ||
| Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor | Q84963968 | ||
| Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer | Q85907155 | ||
| Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 | ||
| Measuring inconsistency in meta-analyses | Q27860655 | ||
| QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies | Q27861031 | ||
| Practical methods for incorporating summary time-to-event data into meta-analysis | Q28131754 | ||
| The miR-34 family in cancer and apoptosis | Q28245865 | ||
| MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion | Q30352893 | ||
| Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data | Q30703091 | ||
| Aggregate data meta-analysis with time-to-event outcomes | Q30742997 | ||
| A method of estimating comparative rates from clinical data; applications to cancer of the lung, breast, and cervix. | Q30898711 | ||
| Meta-DiSc: a software for meta-analysis of test accuracy data. | Q31048578 | ||
| Triple-negative breast cancer in African-American women: disparities versus biology | Q33797203 | ||
| MiR-34a expression has an effect for lower risk of metastasis and associates with expression patterns predicting clinical outcome in breast cancer | Q34079217 | ||
| MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. | Q34107306 | ||
| Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells | Q34145858 | ||
| The diagnostic odds ratio: a single indicator of test performance | Q34276416 | ||
| MicroRNAs expression in triple negative vs non triple negative breast cancer in Tunisia: interaction with clinical outcome | Q34450694 | ||
| National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers | Q34601116 | ||
| Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer | Q34613472 | ||
| The association between abnormal microRNA-10b expression and cancer risk: a meta-analysis | Q34708173 | ||
| Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker | Q35247522 | ||
| The expression and clinical significance of serum miR-205 for breast cancer and its role in detection of human cancers | Q35482100 | ||
| Quantitative assessment of miR34a as an independent prognostic marker in breast cancer | Q35677744 | ||
| An evaluation of preoperative CA 15-3 measurement in primary breast carcinoma | Q36081093 | ||
| TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. | Q36237549 | ||
| Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer | Q36546638 | ||
| Mammography facility characteristics associated with interpretive accuracy of screening mammography | Q36726371 | ||
| Prognostic Value of EMT-inducing Transcription Factors (EMT-TFs) in Metastatic Breast Cancer: A Systematic Review and Meta-analysis. | Q37030764 | ||
| Outcome Disparities in African American Compared with European American Women with ER+HER2- Tumors Treated within an Equal-Access Health Care System | Q37103673 | ||
| MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies | Q37376319 | ||
| Mir-34: a new weapon against cancer? | Q38253374 | ||
| Biomarkers in Breast Cancer: Where Are We and Where Are We Going? | Q38593962 | ||
| MiR-34a regulates therapy resistance by targeting HDAC1 and HDAC7 in breast cancer | Q38961410 | ||
| Cancer Statistics, 2017. | Q39038674 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| meta-analysis | Q815382 | ||
| systematic review | Q1504425 | ||
| breast neoplasm | Q23929670 | ||
| tumor biomarker | Q66205818 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 23177-23187 | |
| P577 | publication date | 2017-04-01 | |
| 2017-04-04 | |||
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | The diagnostic role of microRNA-34a in breast cancer: a systematic review and meta-analysis | |
| P478 | volume | 8 |
| Q90353015 | A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder |
| Q47117322 | Alternative mechanisms of miR-34a regulation in cancer |
| Q64064032 | Anticancer Activities of L. in Experimental Breast Carcinoma in Vivo and in Vitro |
| Q90597836 | Chemopreventive and Therapeutic Efficacy of Cinnamomum zeylanicum L. Bark in Experimental Breast Carcinoma: Mechanistic In Vivo and In Vitro Analyses |
| Q90284850 | Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients |
| Q92038377 | Delphinidin suppresses breast carcinogenesis through the HOTAIR/microRNA-34a axis |
| Q41279583 | Development of diagnostic SCAR markers for genomic DNA amplifications in breast carcinoma by DNA cloning of high-GC RAMP-PCR fragments |
| Q90290617 | Down-Regulated microRNA-34a Expression as a Prognostic Marker for Poor Osteosarcoma in Mice: A Systematic Review and Meta-Analysis |
| Q60960583 | Evaluation of pre-mir-34a rs72631823 single nucleotide polymorphism in triple negative breast cancer: A case-control study |
| Q47721202 | How miRs and mRNA deadenylases could post-transcriptionally regulate expression of tumor-promoting protein PLD. |
| Q55028545 | Improved sensitivity for detection of breast cancer by combination of miR-34a and tumor markers CA 15-3 or CEA. |
| Q58548157 | MicroRNA-34 family in breast cancer: from research to therapeutic potential |
| Q44463289 | MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers. |
| Q64259767 | Roles of MicroRNA-34a in Epithelial to Mesenchymal Transition, Competing Endogenous RNA Sponging and Its Therapeutic Potential |
| Q47122468 | Simultaneous overexpression of miR-126 and miR-34a induces a superior antitumor efficacy in pancreatic adenocarcinoma |
| Q47139724 | miR-34a expression in human breast cancer is associated with drug resistance |
| Q90324389 | miR-34a regulates adipogenesis in porcine intramuscular adipocytes by targeting ACSL4 |
Search more.